ZIVO Bioscience (NASDAQ:ZIVOW) Trading Down 2.4%
ZIVO Bioscience (NASDAQ:ZIVOW) Trading Down 2.4%
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) shares fell 2.4% during trading on Friday . The company traded as low as $0.73 and last traded at $0.83. 1,107 shares were traded during trading, a decline of 79% from the average session volume of 5,230 shares. The stock had previously closed at $0.85.
ZIVO 生物科技股份有限公司 (納斯達克:ZIVO — 獲得評級) 股票在周五交易期間下跌了 2.4%.該公司的交易價格低至 0.73 美元，最後交易價 0.83 美元。在交易期間成交 1,107 股，較 5,230 股平均交易量下跌 79%。該股票之前已收盤 0.85 美元。
ZIVO Bioscience Trading Down 2.4 %
ZIVO 生物科學交易下跌 2.4%
The business's 50-day moving average price is $0.79 and its 200 day moving average price is $0.77.
該企業的 50 天移動平均價為 0.79 美元，200 日移動平均價格為 0.77 美元。
Institutional Inflows and Outflows
機構流入和流出
A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC lifted its stake in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the period. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent SEC filing.
一家對沖基金最近籌集了 ZIVO 生物科學股份的股份。根據其最近向 SEC 提交的文件，沃伯格資產管理有限責任公司（NASDAQ：ZIVOW-獲得評級）在第三季度將其 ZIVO 生物科學公司（NASDAQ：ZIVOW-獲得評級）的股份權益提高了 442.0％。該基金在期內額外收購 69,034 股股份後持有該公司股票 84,654 股。沃伯格資產管理有限責任公司在 ZIVO 生物科學的持股價值為 $51,000 作為其最近的 SEC 備案.
About ZIVO Bioscience
關於滋豐生物科學
(Get Rating)
(取得評分)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc 是一家總部位於密歇根州的生物科技/農業科技公司，致力於利用源自其專有藻類培養物的免疫健康和營養益處。該開發管線包括用作膳食補充劑和功能性食品成分的天然產品，以及創新的，生物衍生和合成的候選物，旨在為人類和動物提供藥用和藥物益處，特別著重於調節免疫和炎症反應。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
- 獲取有關 ZIVO 生物科學研究報告的免費副本
- 2 海上鑽探股票將提取巨額利潤
- 前面有兩位數字的三個主要股票
- 投資者可以信任消費者提升美國戶外品牌嗎？
- 如何購買高收益股息股票
- 甲骨文已經說話:股價下跌 5%
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收 ZIVO 生物科學日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 ZIVO 生物科學及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。